About CoAxia
CoAxia is a company based in Maple Grove (United States) founded in 1999 was acquired by ZOLL AEDs in July 2013.. CoAxia has raised $72.6 million across 4 funding rounds from investors including ZOLL AEDs, Canaan and Sofinnova. CoAxia operates in a competitive market with competitors including Rapid Medical, Cerus Endovascular, Anaconda Biomed, Oxford Endovascular and Fluid Biomed, among others.
- Headquarter Maple Grove, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Coaxia, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CoAxia
CoAxia has successfully raised a total of $72.6M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $22.5 million completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $22.5M
-
First Round
First Round
(01 Jun 2004)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2011 | Amount | Series D - CoAxia | Valuation |
investors |
|
| Jun, 2009 | Amount | Series D - CoAxia | Valuation |
investors |
|
| Sep, 2006 | Amount | Series C - CoAxia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CoAxia
CoAxia has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include ZOLL AEDs, Canaan and Sofinnova. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CoAxia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CoAxia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Coaxia Comparisons
Competitors of CoAxia
CoAxia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, Cerus Endovascular, Anaconda Biomed, Oxford Endovascular and Fluid Biomed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| domain | founded_year | HQ Location |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| domain | founded_year | HQ Location |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| domain | founded_year | HQ Location |
Metallic mesh devices for brain aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CoAxia
When was CoAxia founded?
CoAxia was founded in 1999 and raised its 1st funding round 5 years after it was founded.
Where is CoAxia located?
CoAxia is headquartered in Maple Grove, United States. It is registered at Maple Grove, Minnesota, United States.
Is CoAxia a funded company?
CoAxia is a funded company, having raised a total of $72.6M across 4 funding rounds to date. The company's 1st funding round was a Series C of $11M, raised on Jun 01, 2004.
What does CoAxia do?
CoAxia was developing catheter-based perfusion augmentation therapies to improve outcomes for patients with cerebral ischemia. The core application for CoAxias catheter technology, under the trade names NeuroFlo and FloControl, involves the redistribution of blood flow from the lower extremities to support brain function during ischemia. Acquired by Zoll, an Asahi Kasei Group company in 2013.
Who are the top competitors of CoAxia?
CoAxia's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
Who are CoAxia's investors?
CoAxia has 7 investors. Key investors include ZOLL AEDs, Canaan, Sofinnova, Affinity Capital Management, and Johnson & Johnson Innovation – JJDC.